Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?

Understanding Basic Concepts of Viral Quasispecies: From Evolutionary Dynamics to Clinical Relevance.

Pathogens (Basel, Switzerland)·2026

Evaluating Alpha-1 Antitrypsin Deficiency testing across Europe to ensure diagnostic accuracy: an EARCO multicentre project.

Respiratory research·2026

Peaked-to-flat transition in quasispecies structure evolution.

Virus evolution·2026

Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt.

International journal of molecular sciences·2025

HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T Cells.

Liver international : official journal of the International Association for the Study of the Liver·2025

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants.

Journal of medical virology·2025

Barriers to Viral Hepatitis Elimination and New Strategies to Overcome Them in Low- and Middle-Income Countries.

Journal of hepatology·2026

Emerging strategies for hepatocellular carcinoma surveillance: abbreviated MRI, biomarkers and benefit stratification.

Journal of hepatology·2026

Artificial intelligence and personalised medicine in liver cancer.

Journal of hepatology·2026

Spleen stiffness measurement rules out high-risk varices in patients with chronic portal vein thrombosis without cirrhosis.

Journal of hepatology·2026

Serum HBsAg cannot distinguish cccDNA activity from integrated HBV DNA expression in chronic hepatitis B virus infection.

Journal of hepatology·2026

Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trial.

Journal of hepatology·2026

Quantification of tadalafil in HLMs using an ultrafast UPLC-MS/MS method to assess metabolic stability, including in silico analysis of metabolic lability, DEREK alerts, and ADME characteristics.

Analytical methods : advancing methods and applications·2026

When an AI-generated diagnosis begins to matter: the AI consequence point.

Diagnosis (Berlin, Germany)·2026

Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update).

Mycoses·2026

NAFLD becomes MASLD, frequency and characteristics of non-obese metabolic dysfunction associated steatotic liver disease (MASLD) among patients seeking care at a tertiary medical facility.

JPMA. The Journal of the Pakistan Medical Association·2026

A Dual-Mode In Situ EV-miRNA Profiling Platform for Machine-Learning-Assisted Gastric Cancer Liquid Biopsy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Applications of AI-assisted interpreter Raman spectroscopy platform for rapid and accurate cefotaxime-resistant Escherichia coli classification.

Analytica chimica acta·2026

Related Experiment Videos

Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?

Related Concept Videos

Understanding Basic Concepts of Viral Quasispecies: From Evolutionary Dynamics to Clinical Relevance.

Evaluating Alpha-1 Antitrypsin Deficiency testing across Europe to ensure diagnostic accuracy: an EARCO multicentre project.

Peaked-to-flat transition in quasispecies structure evolution.

Deep Sequencing Analysis of Hepatitis C Virus Subtypes and Resistance-Associated Substitutions in Genotype 4 Patients Resistant to Direct-Acting Antiviral (DAA) Treatment in Egypt.

HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T Cells.

Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants.

Barriers to Viral Hepatitis Elimination and New Strategies to Overcome Them in Low- and Middle-Income Countries.

Emerging strategies for hepatocellular carcinoma surveillance: abbreviated MRI, biomarkers and benefit stratification.

Artificial intelligence and personalised medicine in liver cancer.

Spleen stiffness measurement rules out high-risk varices in patients with chronic portal vein thrombosis without cirrhosis.

Serum HBsAg cannot distinguish cccDNA activity from integrated HBV DNA expression in chronic hepatitis B virus infection.

Elafibranor in primary biliary cholangitis: two-year placebo-controlled outcomes and long-term open-label data from the ELATIVE® phase III trial.

Quantification of tadalafil in HLMs using an ultrafast UPLC-MS/MS method to assess metabolic stability, including in silico analysis of metabolic lability, DEREK alerts, and ADME characteristics.

When an AI-generated diagnosis begins to matter: the AI consequence point.

Central Nervous System Aspergillosis: Advances in Diagnosis, Therapeutics, and Multidisciplinary Management (2026 Update).

NAFLD becomes MASLD, frequency and characteristics of non-obese metabolic dysfunction associated steatotic liver disease (MASLD) among patients seeking care at a tertiary medical facility.

A Dual-Mode In Situ EV-miRNA Profiling Platform for Machine-Learning-Assisted Gastric Cancer Liquid Biopsy.

Applications of AI-assisted interpreter Raman spectroscopy platform for rapid and accurate cefotaxime-resistant Escherichia coli classification.

Related Experiment Videos

Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?

Related Concept Videos

Related Articles